ZIM (NYSE) director sells 5,000 shares, $110K proceeds reported
Rhea-AI Filing Summary
ZIM reporting a Form 144 trade by Eyal Ben Amram: sold 5,000 ordinary shares on 12/23/2025 for $110,000. Shares outstanding were 120,465,908 as of 03/11/2026, provided here as context.
Positive
- None.
Negative
- None.
Insights
Small, routine insider disposition with context showing limited scale.
The filing records a 5,000-share sale by an affiliate on 12/23/2025 for $110,000. The transaction is a disposition reported under Form 144 and is presented as a single past sale.
Shares outstanding are listed as 120,465,908 as of 03/11/2026, which provides scale; the sale represents a small fraction of that total. Cash-flow treatment and any trading plan attribution are not stated in the excerpt.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did ZIM insider Eyal Ben Amram report on Form 144?
The filing shows Eyal Ben Amram sold 5,000 ordinary shares on 12/23/2025 for $110,000. This entry records a disposition under Form 144 and cites the sale amount and date as reported.
Does the excerpt state whether the sale was part of a 10b5-1 plan?
The excerpt does not state a Rule 10b5-1 trading plan or similar arrangement. It only records the sale date, share count, and total proceeds; no pre‑arrangement language appears in the provided text.
Who received the cash proceeds from the reported sale?
The excerpt lists the sale and the proceeds amount of $110,000, but it does not specify the recipient of cash proceeds or whether proceeds went to the selling holder; cash‑flow treatment is not detailed in the excerpt.
Where can I find the official transaction date and amount for the Form 144 entry?
The filing excerpt cites the transaction date as 12/23/2025 and total proceeds as $110,000 for 5,000 ordinary shares. Those exact figures appear in the Form 144 content provided here.